Join
Live feed
·
INSIDERFilingvia Quantisnow
Orchard Therapeutics plc logo

SEC Form 4: Thomas Frank E bought $7,474 worth of Ordinary Shares (10,000 units at $0.75), increasing direct ownership by 24% to 52,081 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ORTX (Orchard Therapeutics plc) and more on Quantisnow.